S 5059
119th Congress • 2025-2027 (Current)

A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.


S 5059
Jul 21, 2026
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.